InvestorsHub Logo
Followers 51
Posts 9209
Boards Moderated 1
Alias Born 10/25/2007

Re: Man6677 post# 11728

Tuesday, 05/17/2022 11:06:41 PM

Tuesday, May 17, 2022 11:06:41 PM

Post# of 13603
mRNA vaccines superior to others in COVID variant antibody response, study finds-
mRNA COVID-19 vaccines manufactured by Moderna (NASDAQ:MRNA) are more effective in producing neutralizing antibodies to variants than other types, according to a new study.
The cohort study, published in PLoS Medicine, included 165 health care workers in the Netherlands vaccinated with one of the two mRNA shots

https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1003991
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRNA News